Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 272 clinical trials
  • None views
  • None views
Combination of PD-1 and VEGFR-2 Blockade for Advanced Hepatocellular Carcinoma

The aie of this clinical study is the safety and efficacy of combination therapy for HCC patients.

liver cancer
total serum bilirubin
measurable disease
granulocyte colony stimulating factor
cancer
  • 0 views
  • 19 Feb, 2024
  • 1 location
Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung Cancer

Results from a pilot clinical study reported the safety and feasibility of neoadjuvant PD-1 blockade. There are several neoadjuvant immunotherapy (NEOSTAR, LCMC3, NADIM, IMpower131) ongoing, and the preliminary results are reported in 2019 American Society of Clinical Oncology, which show promising therapeutic prospect.

metastasis
measurable disease
proto-oncogene tyrosine-protein kinase ros
anticoagulation therapy
neutrophil count
  • 0 views
  • 19 Feb, 2024
  • 1 location
Asian Diabetes Outcomes Prevention Trial

The aim of this study is to identify patients with DM at high risk of CVD using elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels (>125pg/mL), and (2) intensify therapy using renin-angiotensin system (RAS) antagonists, beta-blockers and sodium glucose co-transporter-2 inhibitors (SGLT2i) for primary prevention of cardiovascular events in this high-risk …

type 2 diabetes mellitus
stroke
amputation of the lower limb
niddm
cardiovascular disease
  • 0 views
  • 19 Feb, 2024
  • 1 location
Determination Safety and Tolerability of Epigenetic and Immunomodulating Drugs in Combination With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer.

A multi-center, open-label phase I/II study to to determine the safety and tolerability of Azacitidine and/or Romidepsin in combination with nab-Paclitaxel/Gemcitabine in patients with advanced pancreatic ductal adenocarcinoma (PDAC) (Part 1), followed by sequential immune targeting with programmed death-ligand (PD-L)1 blockade in combination with low-dose Lenalidomide (Part 2) in patients …

metastasis
paclitaxel
pdac
antineoplastic
romidepsin
  • 0 views
  • 19 Feb, 2024
  • 8 locations
Safety and Early Signs of Efficacy of IL12-L19L19.

The purpose of this study is to describe the safety, tolerability and early signs of efficacy of the antibody-cytokine fusion protein IL12-L19L19 in patients with advanced or metastatic solid carcinomas and diffuse large B-cell lymphoma (DLBCL), after previous immune checkpoint blockade therapy. The primary objective of the study is to …

liver cancer
squamous cell carcinoma of the skin
bilateral salpingectomy
urothelial carcinoma
squamous cell carcinoma of head and neck
  • 0 views
  • 19 Feb, 2024
  • 4 locations
Erector Spinae Plane Block After Lumbar Spinal Stenosis Surgery

It involves the injection of local anesthetics into the interfascial plane, deep to erector spinae muscle, allowing the blockade of the dorsal and ventral rami of the thoracic spinal nerves. It was initially proposed for analgesia of costal fractures, pulmonary lobectomy and thoracic vertebrae.

local anesthetic
stenosis
blockade
spinal stenosis
lumbar spinal stenosis
  • 0 views
  • 19 Feb, 2024
  • 1 location
Cryoablation Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer

This early phase I trial studies the side effects and feasibility of cryoablation, atezolizumab, and nab-paclitaxel in treating patients with triple negative breast cancer that has spread to nearby tissue or lymph nodes (locally advanced) or has spread to other places in the body (metastatic). Cryosurgery, also known as cryoablation …

pd-l1
paclitaxel
prognostic stage iii breast cancer ajcc v8
prognostic stage iiib breast cancer ajcc v8
breast tumor
  • 0 views
  • 19 Feb, 2024
  • 1 location
Niraparib/TTFields in GBM

Evaluating the efficacy and safety of niraparib and Tumor-Treating Fields (TTFields) in recurrent glioblastoma (GBM).

recurrent glioblastoma
glioblastoma
karnofsky performance status
renal function test
tumor treating fields therapy
  • 0 views
  • 19 Feb, 2024
  • 1 location